Namocell Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Namocell is a biotechnology research company that develops high-performance systems for single cell sorting and dispensing. Its Single Cell Dispenser platform enables researchers to identify and isolate single cells, nuclei, protoplasts, bacteria, yeast, and fungi in a single step while preserving cell viability and integrity. The technology supports a broad range of applications, including cell line development and engineering, CRISPR and iPSC cloning, single cell genomics, cell and gene therapies, antibody discovery, rare cell isolation, single cell proteomics, and synthetic biology. Namocell is based in Mountain View, California, and operates with a small team focused on enabling advanced single-cell research. The company has historically collaborated with leading research institutions such as Stanford Medicine and Massachusetts General Hospital for circulating tumor cell work, and has engaged in partnerships to extend its reach in the research community. In July 2022, Namocell was acquired by Bio-Techne, a larger life sciences company, integrating its capabilities into a broader portfolio.